Single-Cell Nucleic Acid Barcoding for Minority Population Attribution

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current nucleic acid sequencing technologies struggle to effectively analyze and characterize sub-populations of cells, particularly those representing a minority within a biological sample, due to biases in amplification and attribution methods, leading to inaccurate data and inability to identify individual cell contributions.

Innovation Solution

The method involves compartmentalizing nucleic acids from individual cells into discrete partitions, attaching unique barcode sequences, and sequencing these to attribute characteristics back to the individual cells, allowing for precise characterization of nucleic acids from small populations or individual cells without amplification biases.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional nucleic acid sequencing methods are used, then sequencing can be performed on bulk cell populations, but amplification biases prevent accurate characterization of sub-populations and minority cell contributions

Engineering Contradiction:
Improveattribution accuracyVSAvoiddata accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent segments bulk cell populations into individual cells or small groups through single-cell partitioning techniques. Each partition contains nucleic acids from a single cell or small group of cells, allowing independent sequencing and attribution. This segmentation eliminates amplification biases that occur in bulk methods, as each partition is processed separately without cross-contamination or dominant signal interference from majority cell types.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces barcode sequences as intermediary markers that are attached to nucleic acids from individual cells. These barcodes serve as mediators between the physical cell and the sequencing data, enabling accurate attribution of sequencing results to specific cells. The barcodes allow differentiation between cells that would otherwise be indistinguishable in bulk analysis, resolving the attribution accuracy problem.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Quantity of substance

If amplification methods are used to increase sequencing signal, then sequencing sensitivity improves, but amplification biases distort the representation of minority cell populations

Engineering Contradiction:
Improvenucleic acid amountVSAvoidsub-population representation accuracy
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent performs preliminary actions by attaching barcode sequences to nucleic acids from individual cells before amplification. This preliminary barcoding ensures that even low-abundance sequences from minority cells are tagged and identifiable before amplification occurs. The barcodes are attached at the single-cell level, so amplification of individual partitions does not create biases, as each partition's barcode-coded sequences are independently amplified and tracked.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses barcode sequences as copies or identifiers that travel with the nucleic acids through the sequencing process. Instead of relying on the quantity of nucleic acid molecules for identification, the barcodes provide a discrete, copyable identifier that maintains information about the original cell source. This copying mechanism allows accurate tracking of minority cell contributions even when nucleic acid amounts are low.

Inventive Principle:
Principle #26Copying

3Productivity

If bulk sequencing is performed on heterogeneous samples, then throughput is maintained, but individual cell contributions cannot be identified

Engineering Contradiction:
Improvesequencing throughputVSAvoidcell-level information
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent segments the heterogeneous sample into individual cell partitions while maintaining high throughput through parallel processing. Multiple partitions containing single cells or small groups of cells can be sequenced simultaneously using high-throughput sequencing platforms. The segmentation is achieved through microfluidic devices or droplet-based systems that can process many partitions in parallel, thus maintaining productivity while preserving cell-level information through the barcode attachment method.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS20220098659A1Methods and systems for processing polynucleotides
Publication Date: 2022.03.31 10X GENOMICS INC
  • US20220098659A1 patent drawing
  • US20220098659A1 patent drawing
  • US20220098659A1 patent drawing

AI summary

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing. Such polynucleotide processing may be useful for a variety of applications, including polynucleotide sequencing.